Safety and efficacy of cardiopoietic stem cells in the treatment of post-infarction left-ventricular dysfunction – From cardioprotection to functional repair in a translational pig infarction model

Maximilian Y. Emmert(University of Zurich), Simon P. Hoerstrup(University of Zurich), Volkmar Falk(ETH Zurich), Etem Caliskan(Berlin Heart (Germany)), Arnold von Eckardstein(University Hospital of Zurich), Kevin Kit Parker(Harvard University), Ruth Schwartländer(ETH Zurich), Benedikt Weber(Medical University of Vienna), Petra Wolint(University Hospital of Zurich), Chad E. Brokopp(Swiss Institute for Regenerative Medicine), Viola Vogel(ETH Zurich), Dominika Macejovska(Medical University of Vienna), András Jakab(Medical University of Vienna), Mariann Gyöngyösi(Medical University of Vienna), Thi Dan Linh Nguyen‐Kim(University Hospital of Zurich), Francesco S. Pasqualini(Harvard University), Burkhardt Seifert(Omega Consult (Slovenia)), Monika Hilbe(University of Zurich), Sean P. Sheehy(Harvard University)
Biomaterials
November 23, 2016
Cited by 36


Related Papers